• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION UV ABSORBING IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION UV ABSORBING IOL; INTRAOCULAR LENS Back to Search Results
Model Number DAT015
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code Blurred Vision (2137)
Date of Event 08/23/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A sample device was not returned for analysis.Product history records were reviewed and documentation indicated the product met release criteria.Root cause has not been identified.Two other complaints for lot.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A surgeon reported that following an intraocular lens (iol) implant procedure, the patient experienced blurred vision and myopia.Additional information was received that indicated prior to the iol exchange, a procedure was performed to reposition the iol with a suture.The surgeon stated the optics of the company (implanted) lens may not work with the patient's eye, therefore the iol was exchanged 29 days following the initial implant procedure.
 
Additional Manufacturer Narrative
The customer indicated, the use of a qualified company and company handpiece.The customer indicated, the use of a viscoelastic.Which is not qualified for company cartridge use.Information was provided, that the company lens 16.0 diopter, (1.5 extended depth of focus) lens was replaced with a non-company 15.0 diopter, monofocal lens model.Additional information was provided, that in the surgeon's opinion, the "optics of company lens may not work with the patient's eye".Due to the exchange of a multifocal lens to a monofocal lens, this may suggest, that the replacement lens model was an improved choice for the patient's vision needs.No additional information has been provided at this time.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY EXTENDED VISION UV ABSORBING IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8175514979
MDR Report Key12582428
Report Number1119421-2021-01892
Device Sequence Number3289241
Product Code POE
UDI-Device Identifier00380652424554
UDI-Public00380652424554
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2021
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 11/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/15/2025
Device Model NumberDAT015
Device Lot Number15032709
Was Device Available for Evaluation? No
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/09/2021
Supplement Date Received by Manufacturer11/02/2021
Initial Report FDA Received Date10/06/2021
Supplement Report FDA Received Date11/26/2021
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured02/17/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
AMVISC; MONARCH III CARTRIDGE D; MONARCH III INJECTOR; AMVISC; MONARCH III CARTRIDGE D; MONARCH III INJECTOR
Outcome Attributed to Adverse Event Required Intervention;
Patient Age54 YR
Patient SexFemale
-
-